Annual CFF
$595.70 K
-$1.03 M-63.29%
September 1, 2024
Summary
- As of February 12, 2025, DRUG annual cash flow from financing activities is $595.70 thousand, with the most recent change of -$1.03 million (-63.29%) on September 1, 2024.
- During the last 3 years, DRUG annual CFF has fallen by -$20.01 million (-97.11%).
- DRUG annual CFF is now -97.11% below its all-time high of $20.61 million, reached on September 30, 2021.
Performance
DRUG Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$13.80 K
+$11.50 K+45.45%
September 1, 2024
Summary
- As of February 12, 2025, DRUG quarterly cash flow from financing activities is -$13.80 thousand, with the most recent change of +$11.50 thousand (+45.45%) on September 1, 2024.
- Over the past year, DRUG quarterly CFF has dropped by -$658.80 thousand (-102.14%).
- DRUG quarterly CFF is now -100.07% below its all-time high of $19.54 million, reached on March 31, 2021.
Performance
DRUG Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$595.60 K
+$7600.00+1.29%
September 1, 2024
Summary
- As of February 12, 2025, DRUG TTM cash flow from financing activities is $595.60 thousand, with the most recent change of +$7600.00 (+1.29%) on September 1, 2024.
- Over the past year, DRUG TTM CFF has dropped by -$12.20 thousand (-2.01%).
- DRUG TTM CFF is now -97.28% below its all-time high of $21.91 million, reached on June 30, 2021.
Performance
DRUG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DRUG Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.3% | -102.1% | -2.0% |
| 3 y3 years | -97.1% | -102.1% | -2.0% |
| 5 y5 years | -20.6% | -102.1% | -2.0% |
DRUG Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.1% | at low | -100.3% | +45.5% | -96.9% | +216.3% |
| 5 y | 5-year | -97.1% | at low | -100.1% | +97.8% | -97.3% | +216.3% |
| alltime | all time | -97.1% | at low | -100.1% | +97.8% | -97.3% | +216.3% |
Bright Minds Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $595.70 K(-63.3%) | -$13.80 K(-45.5%) | $595.60 K(+1.3%) |
| Jun 2024 | - | -$25.30 K(+145.6%) | $588.00 K(-3.1%) |
| Mar 2024 | - | -$10.30 K(-101.6%) | $606.90 K(-0.1%) |
| Dec 2023 | - | $645.00 K(-3114.0%) | $607.80 K(-62.5%) |
| Sep 2023 | $1.62 M(-60.1%) | -$21.40 K(+234.4%) | $1.62 M(-71.1%) |
| Jun 2023 | - | -$6400.00(-31.9%) | $5.61 M(-0.3%) |
| Mar 2023 | - | -$9400.00(-100.6%) | $5.62 M(-0.2%) |
| Dec 2022 | - | $1.66 M(-58.1%) | $5.63 M(+38.5%) |
| Sep 2022 | $4.07 M | $3.96 M(>+9900.0%) | $4.07 M(-894.2%) |
| Jun 2022 | - | $8600.00(+975.0%) | -$512.10 K(+75.1%) |
| Mar 2022 | - | $800.00(-99.1%) | -$292.50 K(-101.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $93.80 K(-115.2%) | $19.25 M(-6.6%) |
| Sep 2021 | $20.61 M(+2647.1%) | - | - |
| Sep 2021 | - | -$615.30 K(-369.6%) | $20.61 M(-6.0%) |
| Jun 2021 | - | $228.20 K(-98.8%) | $21.91 M(+1.1%) |
| Mar 2021 | - | $19.54 M(+1242.8%) | $21.68 M(+883.0%) |
| Dec 2020 | - | $1.46 M(+110.5%) | $2.21 M(+194.0%) |
| Sep 2020 | $750.20 K | - | - |
| Sep 2020 | - | $691.20 K(-7375.8%) | $750.10 K(+1173.5%) |
| Jun 2020 | - | -$9500.00(-113.9%) | $58.90 K(-13.9%) |
| Mar 2020 | - | $68.40 K(>+9900.0%) | $68.40 K(>+9900.0%) |
| Dec 2019 | - | $0.00 | $0.00 |
FAQ
- What is Bright Minds Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual CFF year-on-year change?
- What is Bright Minds Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly CFF year-on-year change?
- What is Bright Minds Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM CFF year-on-year change?
What is Bright Minds Biosciences annual cash flow from financing activities?
The current annual CFF of DRUG is $595.70 K
What is the all time high annual CFF for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual cash flow from financing activities is $20.61 M
What is Bright Minds Biosciences annual CFF year-on-year change?
Over the past year, DRUG annual cash flow from financing activities has changed by -$1.03 M (-63.29%)
What is Bright Minds Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of DRUG is -$13.80 K
What is the all time high quarterly CFF for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly cash flow from financing activities is $19.54 M
What is Bright Minds Biosciences quarterly CFF year-on-year change?
Over the past year, DRUG quarterly cash flow from financing activities has changed by -$658.80 K (-102.14%)
What is Bright Minds Biosciences TTM cash flow from financing activities?
The current TTM CFF of DRUG is $595.60 K
What is the all time high TTM CFF for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM cash flow from financing activities is $21.91 M
What is Bright Minds Biosciences TTM CFF year-on-year change?
Over the past year, DRUG TTM cash flow from financing activities has changed by -$12.20 K (-2.01%)